Cleaning up the Antibacterial Resistance Mess
September 21st 2016Antimicrobial resistance presents a challenge on a global scale that has received attention from the United Nations General Assembly among other governing bodies. Research and development for new antimicrobials and alternative medicines is needed to combat such a threat.
NIH, FDA Seek Broader Disclosure of Clinical Trial Results
September 19th 2016After months of debate, clinical research activity regulated or funded by the government must adhere to revised guidelines regarding transparency. A final rule published by the Department of Health and Human Services states that all beyond Phase I FDA regulated and NIH funded clinical trials must comply with the new requirements.
Technology That Touches the Patient
September 14th 2016What used to be segregated approaches in clinical trials-ePRO, telemedicine, mobile health, devices and wearables-now gather under the umbrella of technologies that touch the patient. And those technologies can have positive implications for costs efficiencies in clinical trials, streamlined data collection, as well as on patient compliance and retention.